Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1401066-79-2
2. Bms 906024
3. Osugacestat
4. Osugacestat [usan]
5. Al101
6. Drl23n424r
7. (2r,3s)-n1-((s)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)succinamide
8. Al-101
9. Bm0018
10. Bm-0018
11. (2s,3r)-n'-[(3s)-1-methyl-2-oxo-5-phenyl-3h-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide
12. Unii-drl23n424r
13. Osugacestat [inn]
14. Chembl4297269
15. Schembl12543868
16. Dtxsid30161234
17. Chebi:131164
18. Mfcd24849414
19. Nsc780812
20. Who 11648
21. Bms 906024 [who-dd]
22. Zinc100285156
23. Db12006
24. Nsc-780812
25. Bb162475
26. Hy-15670
27. Cs-0008191
28. Bms-906024, >=98% (hplc)
29. Q15408421
30. (2r,3s)-n1 -((3s)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-1,4- Benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)butanediamide
31. Butanediamide, N1-((3s)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluorophenyl)-, (2r,3s)-
32. Butanediamide, N1-((3s)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1h-1,4-benzodiazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)-, (2r,3s)-
| Molecular Weight | 556.5 g/mol |
|---|---|
| Molecular Formula | C26H26F6N4O3 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 556.19090968 g/mol |
| Monoisotopic Mass | 556.19090968 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 916 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
28
PharmaCompass offers a list of AL101 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AL101 manufacturer or AL101 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AL101 manufacturer or AL101 supplier.
PharmaCompass also assists you with knowing the AL101 API Price utilized in the formulation of products. AL101 API Price is not always fixed or binding as the AL101 Price is obtained through a variety of data sources. The AL101 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AL101 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AL101, including repackagers and relabelers. The FDA regulates AL101 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AL101 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AL101 supplier is an individual or a company that provides AL101 active pharmaceutical ingredient (API) or AL101 finished formulations upon request. The AL101 suppliers may include AL101 API manufacturers, exporters, distributors and traders.
AL101 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AL101 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AL101 GMP manufacturer or AL101 GMP API supplier for your needs.
A AL101 CoA (Certificate of Analysis) is a formal document that attests to AL101's compliance with AL101 specifications and serves as a tool for batch-level quality control.
AL101 CoA mostly includes findings from lab analyses of a specific batch. For each AL101 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AL101 may be tested according to a variety of international standards, such as European Pharmacopoeia (AL101 EP), AL101 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AL101 USP).
